Related Experiment Video
Updated: Jun 5, 2026
07:10
Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
Published on: August 24, 2019
[Tiotropium bromide for treating chronic obstructive pulmonary disease].
Eksperimental'Naia I Klinicheskaia Farmakologiia
|January 25, 2011
Summary
Tiotropium bromide offers a new therapeutic option for chronic obstructive pulmonary disease (COPD) by selectively blocking muscarinic receptors M1 and M3. Unlike ipratropium bromide, it avoids M2 blockade, preventing bronchoconstriction and improving COPD management.
Area of Science:
- Pharmacology
- Respiratory Medicine
Context:
- Muscarinic receptors (M1, M2, M3) play roles in airway smooth muscle function.
- Ipratropium bromide, a nonselective anticholinergic, blocks M1, M2, and M3 receptors.
- M2 receptor blockade can cause bronchoconstriction, complicating COPD treatment.
Purpose:
- To introduce tiotropium bromide as a novel therapeutic agent for COPD.
- To compare the receptor-blocking profile of tiotropium bromide with ipratropium bromide.
- To highlight the clinical advantages of tiotropium bromide in COPD management.
Summary:
- Tiotropium bromide selectively inhibits M1 and M3 muscarinic receptors, sparing the M2 subtype.
- This selective action avoids the M2-mediated bronchoconstriction associated with ipratropium bromide.
- Once-daily administration of tiotropium bromide enhances its clinical utility.
Impact:
- Tiotropium bromide represents a significant advancement in COPD pharmacotherapy.
- Selective M1 and M3 blockade offers a potentially safer and more effective treatment strategy.
- Improved patient compliance due to once-daily dosing is anticipated.
Related Concept Videos
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
01:29Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.